Tianjin Chase Sun Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
This assessment of Tianjin Chase Sun Pharmaceutical Co Ltd was prepared by All Street Sevva using cutting edge machine learning. Scroll down to the bottom of this webpage for potential risks for Tianjin Chase Sun Pharmaceutical Co Ltd based on sector, geography and marketcap. This Disclosure score includes 17 United Nations Sustainable Development Goals including: 'Good Health & Wellbeing', 'Climate Action' and 'Partnerships for the Goals'.
Tianjin Chase Sun Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Tianjin Chase Sun Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Tianjin Chase Sun Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Tianjin Chase Sun Pharmaceutical Co Ltd report the average age of the workforce?
Does Tianjin Chase Sun Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Tianjin Chase Sun Pharmaceutical Co Ltd offer flexible work?
Does Tianjin Chase Sun Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Tianjin Chase Sun Pharmaceutical Co Ltd conduct supply chain audits?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Tianjin Chase Sun Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose water use targets?
Does Tianjin Chase Sun Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Tianjin Chase Sun Pharmaceutical Co Ltd have a product recall in the last two years?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Tianjin Chase Sun Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Tianjin Chase Sun Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose parental leave metrics?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Tianjin Chase Sun Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Tianjin Chase Sun Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Tianjin Chase Sun Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose its waste policy?
Does Tianjin Chase Sun Pharmaceutical Co Ltd report according to TCFD requirements?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose energy use targets?
Does Tianjin Chase Sun Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Tianjin Chase Sun Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Tianjin Chase Sun Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and marketing of various pharmaceutical products in China. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet based therapy. It is also involved in the research and development of various drugs in the areas of sepsis, pulmonary hypertension, leukemia, cardiovascular and cerebrovascular diseases, arthritis, ischemic stroke, HCV, vascular disease, psychosis, and chemotherapy, as well as anesthesia drugs and immunomodulators. The company was founded in 1996 and is based in Tianjin, China.